Clinical Trial: A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07682506) titled 'A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo' on June 28.

Brief Summary: This is a randomized, double-blind, multicenter, placebo-controlled clinical study intended to evaluate the efficacy, safety and population pharmacokinetic profiles of MH004 ointment in eligible participants with NSV.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Vitiligo

Intervention: DRUG: MH004 1.0% Ointment

MH004 1% ointment applied topically to the affected area as a thin film twice a day (BID).

DRUG: MH004 Placebo Ointment

MH004 Placebo ointment applied topically to th...